Global Pharmaceutical Blister Packaging Market 2025 – 2034

Reports Description

As per the Pharmaceutical Blister Packaging Market analysis conducted by the BRI Team, the global pharmaceutical blister packaging market is expected to record a CAGR of 7.72% from 2025 to 2034. In 2025, the market size is projected to reach a valuation of USD 23.90 Billion. By 2034, the valuation is anticipated to reach USD 46.65 Billion.

Pharmaceutical Blister Packaging Market Overview

Pharmaceutical blister packing is a widely accepted solution for protecting solid dose medication such as tablets, capsules, and lozenges. Blister packing offers a safe, tamper-evident closure that maintains the integrity of the product, shelf life, and accurate dosing in patients.

The pack is a moulded plastic cup in a backing material, usually aluminium or paperboard. Its unit-dose presentation ensures compliance, safety, and traceability—the pillar of healthcare systems today. As patients demand more portable and convenient packages, blister packs are replacing bulk packages more and more often.

The international market is stimulated by increasing prevalence of chronic illnesses, elderly population, and expanding usage of over-the-counter medicines. Furthermore, the need for stronger regulatory conditions and emphasis on environmentally friendly packaging has encouraged producers to develop unique recyclable and eco-friendly packaging materials.

Smart packaging elements such as QR codes and RFID tags are also included by manufacturers to track and monitor goods and materials in the supply chain more efficiently. With increasing demand from developed as well as emerging economies, pharmaceutical blister packaging is a critical part of the healthcare packaging sector.

Pharmaceutical Blister Packaging Market Key Growth Drivers

The Pharmaceutical blister packaging market Trends has tremendous growth opportunities due to several reasons:

• Increased Demand for Oral Solid Dosage Forms (OSDFs): Oral Solid Dosage Forms (OSDFs) like capsules and tablets are the most common pharmaceutical products owing to their convenience, stability, and affordability. Blister packaging is especially ideal for OSDFs, providing unit-dose packaging that maximizes patient compliance and maintains product integrity. The growing global prevalence of chronic diseases and the aging population have further boosted the demand for OSDFs, thus necessitating effective blister packaging solutions. For example, in October 2023, the blister packaging market is growing at a fast rate due to increased consumer demand for convenience, portability, and product safety in industries like pharmaceuticals, consumer goods, electronics, and food. The biggest user is the pharmaceutical industry, spurred by demand for product integrity and tamper-evident. Sustainability, customization, child-resistant packaging, and advanced print technologies are powering the market. Firms are embracing green material and creative alternatives to address legislative requirements and demand from consumers to create a convenient solution in blister packaging for defense and branding purposes.

• Higher Incidence of Chronic Diseases: With the higher incidence of chronic diseases such as diabetes, cardiovascular disease, and cancer worldwide, oral medicines have been in great demand. Blister packaging leads this development by providing a safe and secure method of packaging such medicines. It keeps drugs away from environmental factors like light and humidity, maintains appropriate dosage through unit-dose packaging, and helps in patient compliance through easy-to-read and handy presentations. This type of packaging is particularly helpful for long-term therapy, ensuring safety and convenience for patients with chronic illnesses.

• Aging Global Population: The aged global population is one of the major drivers in the pharmaceutical blister packaging market due to the tendency among older populations to require consuming more than a single drug as a way to address multiple ailments. Blister packaging offers such an organized, user-friendly product for this cohort with clearly labelled medication that is separately packaged to improve convenience. The unit-dose packaging prevents dosing errors, which is particularly important in elderly patients who may have trouble with complex medication regimens. The packaging also enhances medication compliance by facilitating easy taking of the correct amounts at the correct times.

Pharmaceutical Blister Packaging Market Key Threats

The Pharmaceutical blister packaging market has some primary threats that will influence its profitability and future development. Some of the threats are:

• Unstable Raw Material Prices: The pharmaceutical blister packaging industry depends heavily on raw materials such as plastics and aluminum. Unstable prices of these raw materials may seriously impact production cost, which, in turn, will make the end product costly for the consumer. This volatility acts as a hindrance to manufacturers in keeping cost-effective operations. For example, in April 2025, Johnson & Johnson announced robust first-quarter 2025 results, beating Wall Street forecasts with increased revenue and profit. The growth was fueled by a 20% year-over-year rise in sales of cancer drugs, especially Darzalex, which posted $3.24 billion. The firm lifted its full-year sales guidance by $0.7 billion to a range of $91.6 billion to $92.4 billion, driven by the Intra-Cellular Therapies acquisition and inclusion of schizophrenia drug Caplyta. J&J, though, reduced its profit estimate owing to tariffs and costs associated with acquisitions. While oncology and new pharmaceuticals propelled expansion, Stelara sales, a psoriasis treatment, fell over 33% after biosimilar erosion, and the medtech segment is expected to fare better in the second half of the year.

• Fake Risks: Spurious drugs pose a serious threat to public health and safety. Blister packs, having tamper-evident capabilities, are crucial to combat spurious drugs by providing identifiable signals of tampering and ensuring the authenticity of the product. For instance, in April 2024, the “Protected QR Code-based Anti-counterfeit System for Pharmaceutical Manufacturing” article presents the increasing problem of counterfeiting of drugs by suggesting a novel anti-counterfeit system based on protected QR codes. The system integrates secure generation of QR codes with encrypted data transmission to protect exclusive product information, rendering it inaccessible to standard QR code scanners and thus preventing duplication and tampering. Scalable in design, the method can be applied without changing current supply chain procedures, and it provides a practical and viable way to increase pharmaceutical supply chain security and fight counterfeiting worldwide.
  

Pharmaceutical Blister Packaging Market Opportunities

• Smart Packaging Technology Implementation: Smart packaging involves the incorporation of new technology into packaging to enhance function, such as monitoring product conditions, safety improvement, and the delivery of interactive features. For the pharmaceutical industry, smart blister packaging can include time-temperature indicators, RFID tags, and QR codes that assist in tracking, authentication, and medicine compliance. For instance, at PharmaPack in March 2025, the experts exchanged pharma packaging concerns such as counterfeiting and supply chain interference. Some of the innovations that were showcased comprised smart bottles and blisters with onboard sensors to monitor, remind, and transmit information to healthcare professionals to improve patient outcomes and supply chain clarity. AI-powered authentication and serialization were also showcased to promote security and compliance. Safe, scalable data sharing was determined to be the key to meeting mounting regulatory requirements and establishing a safe, networked pharma community.

• Emerging Markets Growth: Emerging markets present vast growth opportunities for the pharmaceutical blister packaging market with growing access to healthcare, rising disposable incomes, and nascent pharmaceutical industries. These nations are facing a tremendous surge in demand for pharmaceutical drugs, thus creating a need for efficient and safe packaging. For instance, in May 2025, India started producing 38 active pharmaceutical ingredients (APIs) in the last 1.5 years, freeing itself from imports, particularly Chinese imports, as the government initiated its Rs 15,000-crore Production-Linked Incentive (PLI) scheme. Union Health Minister Mansukh Mandaviya was prompt to highlight this success story during a healthcare summit at IIM Ahmedabad, calling it a significant step in the direction of “Atmanirbhar Bharat” (self-reliant India). The project will make the critical APIs locally available and consolidate the pharma industry. Mandaviya also repeated the government’s initiatives to increase medical education, access to healthcare, and support R&D and innovation in the sector to further propel self-reliance and affordability in healthcare.

Pharmaceutical Blister Packaging Market Category Wise Insights

By Material

• Plastic: Plastic packaging materials such as PVC (polyvinyl chloride), PET (polyethylene terephthalate), and PP (polypropylene) are widely used in pharmaceutical blister packing since they are flexible, transparent, and affordable. They have effective moisture and gas barriers that ensure product stability and shelf life. They are easy to mold into different sizes and shapes since they are temperature-sensitive and are thus thermoformable. For example, in October 2024, Bayer and Liveo Research launched a sustainable PET blister pack for its Aleve brand, replacing PVC to improve recyclability and minimize environmental footprint. The new pack lowers carbon emissions by 38%, uses significantly less water and land, and is 18% lighter than regular packaging, without additional cost to the consumer. First introduced in the Netherlands, Bayer intends to roll it out across the world, reasserting its commitment to circular solutions and sustainable health. The program also includes the implementation of business partners to invest in improving recycling centers as well as adopting green drug packaging strategies.

• Aluminum Foil: Aluminum foil is also used in blister packaging due to its better barrier properties that keep drugs away from water, oxygen, and light. It is widely used in cold-form blister packs for stability as well as shelf life. For instance, during September 2024, the thickness of Aluminum foil is a very critical component in pharmaceutical blister packaging that ensures product sustainability, shelf life, and safety. Thicker foils (30 microns and over) create tougher barriers to water, oxygen, and light and improve seal strength and stability of drugs. Reducing the risk of damage as well as contamination at the same time, they add material costs too. Blister packs of plain type employ mostly 20–25 micron foil at an economical price, but drugs requiring extremely delicate handling require thicker grades. The selection of the appropriate thickness of the foil is the key to improving performance, decreasing cost, and achieving maximum medication safety.

• Paper: Paper-based blister packaging provides a more environmentally friendly option, conserving plastic usage and improving recyclability. It is most appropriate for over-the-counter drugs and supplements, providing adequate protection but being green-friendly. For example, Keystone Folding Box introduced Push-Pak, a new paperboard-based blister wallet for pharmaceutical tablets, in June 2024. The new packaging includes a straightforward push-through opening mechanism, making it easy to use and eliminating the need for instructions. Push-Pak’s small form factor minimizes package size overall, and not needing peel-push or paper-backed lidding foil allows lower-cost materials such as tempered foil to be utilized. The alternative solution is proposed to provide an improved, sustainable, cost-saving, and convenient one compared to plastic blister packs that are traditionally used in the pharma sector.

By Technology

• Cold Forming: Cold forming is the process of cold shaping aluminum-plastic laminate film to produce high-barrier blister packs to safeguard sensitive medicines from the surrounding environment. Cold forming is particularly suitable for light- and moisture-sensitive drugs. For example, in July 2024, Cold form blister packaging includes a clear plastic blister space with room temperature-shaped aluminum-plastic laminate to provide material hardness and efficient protection from light, moisture, and air. This provides extended shelf life for products, preserves drug quality, and exhibits a tamper-evident and counterfeit-proof look. With ensured transparency, cost savings, and consistency with automated production, it is most pertinent to tablets, capsules, medical equipment, and diagnostic kits, and hence, the future of pharma and healthcare.

• Thermoforming: Thermoforming utilizes heat for plastic film to form blister cavities for cost savings and design convenience. It is applied primarily with blister pack capsules and tablets and comprises high-speed processing and visible product. Here, for example, in January 2025, Amcor’s white paper “Rising to Sustainability Targets” speaks of the transformation of the healthcare sector towards sustainable, recycle-ready packaging as customers and regulatory forces mount. It introduces the AmSky Blister System—a fully polyolefinic, recyclable package that reduces environmental impact without sacrificing product protection and compliance. The article also mentions critical issues such as rigid package needs and requalification expense, which represent a balance between business needs and sustainability. AmSky is an example of such solutions that offer a way to assist pharmaceutical companies in achieving sustainability goals and plastic waste reduction without compromising performance.

• Heat Seal: Heat seal is a sealing technique that employs the elements of the blister pack by applying heat and pressure to maintain product integrity and tamper evidence. It is a critical process in preserving the sterility and safety of pharmaceutical products. For instance, Mitsui Chemicals India’s February 2021 newsletter states innovative solutions for the pharmaceutical and industrial sectors. Major characteristics are ChemiPearl XSP, a water-based heat seal coating of strong seal strength, best for heat-sensitive pharmaceuticals, and the Bonron XPS Series, a non-toxic, eco-friendly, water-based emulsion with excellent adhesion and high heat, water, and chemical resistance-ideal for PET film use. The newsletter also highlights cutting-edge elastomers for the automotive and industrial markets, including Metallocene VNB-EPT (known for durability and cost-effectiveness) and Metallocene EBT (softer with less fogging and oil bleeding). These developments reflect Mitsui Chemicals’ dedication to sustainable, high-performance products across sectors.

By End Use

• Tablets & Capsules: Blister pack tablets and capsules provide unit-dose packaging, which improves patient compliance and dosage accuracy. It keeps the drug away from the external environment and gives tamper evidence. For example, in March 2021, the paper “Accelerated Medicines Development using a Digital Formulator and a Self-Driving Tableting DataFactory” describes a data-driven, automated platform for accelerating tablet formulation and manufacturing. Blending predictive modeling, optimization, and robotics, it employs a Digital Formulator to determine optimal conditions and a Self-Driving DataFactory to dose, compress, and test autonomously. The platform facilitates in-spec tablets in less than 6 hours with low API and up to 1,440 tablets with real-time quality control within 24 hours. Proven with several APIs, it offers a quicker, more efficient, and resource-saving approach to pharmaceutical development.

• Medical Equipment: Blister pack medical device packaging is important to product sterility and immunity to contamination by handling and shipping. It’s typically used with one-time-use medical devices like syringes, catheters, and medical diagnostic equipment and provides hermetic and tamper-evident packaging that ensures product integrity through the point of use. This pack design not only satisfies severe hygiene and safety criteria but also invites user convenience in the form of clear vision and peel-open packaging, thus being particularly suited for application in hospitals, clinics, and emergencies.

• Injectables: Blister pack injectables deliver injectables in pre-filled ampoules and injectables in pre-filled syringes with protection and sterility. It protects them from harmful handling and storage and keeps the injectable medicine effective. For example, in April 2025, top-load packaging is more popular in the injectable pharma industry for its effectiveness, flexibility, and rigorous protection. Ready-to-erect, supplied in this way, it saves labor and streamlines both automated and manual processes across production volumes. Engineered to safely store vials, syringes, and auto-injectors, it also promotes sustainability through recyclable materials and minimized waste. Thisers top-load packaging a convenient, environmentally friendly option that addresses the changing needs of injectable drug packaging.

Pharmaceutical Blister Packaging Market Impact of Latest Tariff Policies

Changes in tariff policies by major countries worldwide have caused the ripple effect within the pharmaceutical blister packaging industry. Duties levied on materials such as plastic films and aluminum have increased costs of production for producers. Export-oriented countries heavily dependent on the importation of packaging parts are now experiencing the surge in the cost of inputs. This is disrupting the process of pricing mechanisms and planning in operations. Several organizations are now reviewing their international supply chains.

In retaliation, companies are turning to regional vendors or shifting towards local procurement to reduce tariff exposure. Certain multinationals are stepping up investment in local manufacturing facilities to lower dependence on cross-border imports. The transition is quite noticeable in North America and certain parts of Europe. Trade tensions have also prompted companies to employ flexible models of sourcing. These models aim to provide business continuity in the face of changing trade policies.

Although tariffs will spur local manufacturing, they also threaten to drive up drug prices worldwide. Small companies in emerging markets will face rising packaging costs, which will reduce medicine affordability. Uncertainty resulting from shifting tariffs is also postponing long-term investment in packaging innovation. To ensure continued access to low-cost medicines globally, governments and industry leaders need to balance solutions. A joint approach can stabilize supply chains while serving local economies.

Report Scope

Feature of the Report	Details
Market Size in 2025	USD 23.90 Billion
Projected Market Size in 2034	USD 46.65 Billion
Market Size in 2024	USD 22.47 Billion
CAGR Growth Rate	7.72% CAGR
Base Year	2024
Forecast Period	2025-2034
Key Segment	By Material, Technology, End Use and Region
Report Coverage	Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope	North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options	Request tailored purchasing options to fulfil your requirements for research.

Pharmaceutical Blister Packaging Market Regional Perspective

The Pharmaceutical blister packaging market can be divided across different regions such as North America, Europe, Asia-Pacific, and LAMEA. This is a cursory overview of each region:

• North America: The North American pharmaceutical blister pack industry is characterized by stringent regulatory requirements and greater focus on patient safety. The growing demand for tamper-evident and child-resistant packs has led companies to develop innovative solutions that provide exact dosing, prevent contamination, and improve medication compliance. Pharmaceutical companies are also adopting eco-friendly materials for compliance with environmental regulations. These trends collectively are driving packaging innovations to guarantee safety as well as sustainability in the marketplace.

• Europe: The European market for pharmaceutical blister packaging is increasing due to increased demand for green and sustainable packaging solutions. Pressure from consumers and regulation is driving companies to utilize recyclable packaging materials and new packaging structures. For instance, in February 2024, ViiV Healthcare introduced a new blister pack format for Dovato in the US, designed to provide greater discretion and convenience to people with HIV. The monthly 30-count blister pack includes five perforated, credit card-style sheets, allowing for easier tracking of doses and discreet transport. Developed in reaction to consumer input over stigma and convenience, the new pack format supports the bottle and will be introduced to specific European markets throughout 2024.

• Asia-Pacific: The Asia-Pacific is experiencing increased growth in pharmaceutical blister packaging because of increasing health awareness and the necessity for safe drug delivery. Partnerships and innovations are the future to respond to the diverse needs of the continent. For instance, Aptar CSP Technologies and Porton Pharmatech formed a strategic partnership in August 2023 to offer innovative active packaging solutions to enhance the stability, shelf life, and security of medicines. With the combined strength of Aptar’s innovative material science expertise and Porton’s pharmaceutical development capabilities, the joint venture aims to introduce innovative, protective packaging that safeguards drugs from moisture, oxygen, and ambient conditions—meeting the evolving needs of the Chinese and global pharmaceutical market.

• LAMEA: The LAMEA pharmaceutical blister packing market is growing with increasing healthcare spending and the requirement for cost-effective and efficient packaging. In Brazil and Mexico, companies are using new packaging technologies and environmentally friendly packages to improve packaging. In the Middle East and African countries, nations like Saudi Arabia are looking for better packaging regulations to achieve medicine safety standards. Producers are also increasing manufacturing and counting on automated lines to create blister packaging faster and more affordably. The innovations are helping the region to meet the growing demand for high-quality health packs.

Pharmaceutical Blister Packaging Market Key Developments

In recent years, the Pharmaceutical blister packaging market has experienced several crucial changes as the players in the market strive to grow their geographical footprint and improve their product line and profits by using synergies.

• In October 2024, Dow announced the winners of its 2024 Packaging Innovation Awards, recognizing breakthroughs in sustainability, technology, and user experience across the packaging industry. Top honors went to innovations like Panasonic Energy and TOPPAN INFOMEDIA’s paper-based dry battery bag, which significantly reduces material use and CO2 emissions. Other notable winners include recyclable cosmetic bottles, packaging made from bio-circular materials, heat-shrink labels from recycled PET, and India’s first recyclable stand-up pouch for handwash. The awards, judged by an international panel, highlight advancements that improve recyclability, reduce environmental impact, and enhance accessibility, reflecting the industry’s ongoing commitment to sustainable packaging solutions.

• In November 2024, Rohrer Corporation launched EcoVolve, a sustainable packaging line starting with EcoVolve-30, a C1S blister board made with 30% post-consumer recycled (PCR) fiber. Designed to reduce environmental impact without compromising quality, it offers strong durability, superior print performance, and FDA compliance—supporting brands’ sustainability goals. This launch strengthens Rohrer’s role in eco-friendly packaging innovation for the retail and pharmaceutical sectors.

• In October 2023, Solvay introduced a new high-barrier polyvinylidene chloride (PVDC) coating that enhances the sustainability of blister packaging. This innovative coating improves the protection of sensitive products, such as pharmaceuticals, by providing superior moisture and oxygen barriers while using less material. As a result, blister packs can be made thinner and lighter, reducing plastic usage and environmental impact. The new PVDC coating also supports recyclability and aligns with industry efforts to create more eco-friendly packaging solutions. These important changes facilitated the companies to widen their portfolios, to bolster their competitiveness, and to exploit the possibilities for growth available in the Pharmaceutical blister packaging market. This phenomenon is likely to persist since most companies are struggling to outperform their rivals in the market.

Pharmaceutical Blister Packaging Market Competitive Landscape

The Pharmaceutical blister packaging market is highly competitive, with a large number of product providers globally. Some of the key players in the market include:

• ACG
• Amcor
• Aptar
• Borealis
• Caprihans
• Carcano
• Constantia
• Dow
• Honeywell
• Huhtamaki
• Renolit
• Rohrer
• Romaco
• Sonoco
• Sudpack
• Syensqo
• Tekni-Plex
• Tjoapack
• VinylPlus
• WestRock
• Winpak
• Others

These firms apply a sequence of strategies to enter the market, including innovations, mergers, and acquisitions, as well as collaboration.

The Pharmaceutical blister packaging market is driven by major players such as ACG, Amcor, Aptar, Borealis, and Caprihans that provide essential packaging solutions ensuring safety, durability, and efficacy for pharmaceutical medicines. They encourage innovation by creating tamper-evident, child-resistant, and environmentally friendly packaging according to regulatory requirements and patient adherence. With global presence and a strong R&D platform, these players are major partners for pharma companies in search of credible and innovative packaging solutions.

Smaller players such as Uflex and Essentra are also playing their part by emphasizing intelligent, sustainable packaging solutions through the use of technologies like recyclable materials and digital printing. Their end-to-end offerings allow pharmaceutical companies to address market needs effectively while ensuring cost-effectiveness and sustainability, especially in markets with stringent regulatory pressures on packaging.

Local companies in developing markets, like India and Latin America, are teaming up with international companies to offer cost-effective and scalable blister packing solutions to SMEs. These alliances are opening up packaging to more businesses, allowing small and medium-sized companies to achieve quality and safety benchmarks while fostering competition and innovation in the industry.

The Pharmaceutical Blister Packaging Market is segmented as follows:

By Material

• Plastic
• Aluminum foil
• Paper

By Technology

• Cold forming
• Thermoforming
• Heat seal

By End Use

• Tablets & capsules
• Medical devices
• Injectables

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America

[embedsocial_reviews id=”d4ae80cffae3d938f997111953699a733c8e6f99″]